Testing the Addition of Copanlisib to Usual Treatment (Fulvestrant and Abemaciclib) in Metastatic Breast Cancer

Clinical trial NCT03939897 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03939897
Sponsor: National Cancer Institute (NCI)
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Anatomic Stage IV Breast Cancer AJCC v8 Metastatic Breast Carcinoma Metastatic HER2-Negative Breast Carcinoma Metastatic Hormone Receptor-Positive Breast Carcinoma Recurrent Breast Carcinoma

Start date: 2020-06-17
Primary completion: 2023-06-22
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.